Search Results for "zolmitriptan"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for zolmitriptan. Results 1 to 10 of 10 total matches.
See also: Zomig

Zolmitriptan for Migraine

   
The Medical Letter on Drugs and Therapeutics • Feb 27, 1998  (Issue 1021)
Zolmitriptan for Migraine ...
Zolmitriptan (Zomig - Zeneca), a selective serotonin (5-HT1)-receptor agonist, is now available in the USA for oral treatment of migraine headache. Zomitriptan structurally resembles sumatriptan (Imitrex - Medical Letter 34:91, 1992). Drugs currently used for acute treatment of migraine include injectable, oral and nasal spray formulations of sumaptriptan, injectable dihydroergotamine, dihydroergotamine nasal spray, ergotamine tartrate alone or with caffeine, and various analgesics. Anoterh 5-HT1-receptor agonist, naratriptan (Amerge - Gaxo Wellcome), has been approved by the FDA but has not...
Med Lett Drugs Ther. 1998 Feb 27;40(1021):27-8 |  Show IntroductionHide Introduction

Zolmitriptan (Zomig) Nasal Spray for Migraine

   
The Medical Letter on Drugs and Therapeutics • Jan 19, 2004  (Issue 1174)
Zolmitriptan (Zomig) Nasal Spray for Migraine ...
Zolmitriptan (Zomig - AstraZeneca) nasal spray was recently approved by the FDA for treatment of migraine. It is the second selective serotonin receptor agonist ("triptan") to become available as a nasal spray; sumatriptan has been available in this form since 1997. Some patients with migraine cannot take tablets because of nausea and vomiting, and nasal sprays are more convenient than subcutaneous injections.
Med Lett Drugs Ther. 2004 Jan 19;46(1174):7-8 |  Show IntroductionHide Introduction

Onzetra Xsail - Sumatriptan Nasal Powder

   
The Medical Letter on Drugs and Therapeutics • Jul 18, 2016  (Issue 1499)
of migraine in adults. Nasal spray formulations of sumatriptan (Imitrex) and zolmitriptan (Zomig ...
The FDA has approved Onzetra Xsail (Avanir), a nasal powder formulation of sumatriptan, for acute treatment of migraine in adults. Nasal spray formulations of sumatriptan (Imitrex) and zolmitriptan (Zomig) have been available for many years.
Med Lett Drugs Ther. 2016 Jul 18;58(1499):92-3 |  Show IntroductionHide Introduction

Comparison Table: Triptans for Migraine (online only)

   
The Medical Letter on Drugs and Therapeutics • Jun 12, 2023  (Issue 1678)
Almotriptan Eletriptan Frovatriptan Naratriptan Rizatriptan Sumatriptan1 Zolmitriptan Brand Name ...
View the Comparison Table: Triptans for Migraine
Med Lett Drugs Ther. 2023 Jun 12;65(1678):e97-9   doi:10.58347/tml.2023.1678b |  Show IntroductionHide Introduction

Almotriptan (Axert) and Frovatriptan (Frova) for Migraine

   
The Medical Letter on Drugs and Therapeutics • Feb 18, 2002  (Issue 1124)
hour 53.59 2.5 or 5 mg orally; can be repeated in two hoursZolmitriptan − Zomig (AstraZeneca)† 14.70 ...
Almotriptan (Axert - Pharmacia), and Frovatriptan (Frova - Elan) have been approved by the FDA for oral treatment of migraine headache (Drugs of Choice from The Medical Letter 2001, page 131.).
Med Lett Drugs Ther. 2002 Feb 18;44(1124):19-20 |  Show IntroductionHide Introduction

A Fixed-Dose Combination of Sumatriptan and Naproxen for Migraine

   
The Medical Letter on Drugs and Therapeutics • Jun 16, 2008  (Issue 1288)
the nasal spray. 1 Other triptans are available for oral use, and zolmitriptan (Zomig) is also available ...
The FDA has approved an oral, fixed-dose combination (Treximet - GlaxoSmithKline) of the selective serotonin receptor agonist ("triptan") sumatriptan (Imitrex) and the nonsteroidal anti-inflammatory drug (NSAID) naproxen sodium (Anaprox, and others) for acute treatment of migraine attacks.
Med Lett Drugs Ther. 2008 Jun 16;50(1288):45-6 |  Show IntroductionHide Introduction

Eletriptan (Relpax) for Migraine

   
The Medical Letter on Drugs and Therapeutics • Apr 28, 2003  (Issue 1155)
; can be repeated once after 1 hour 57.96 Zolmitriptan − Zomig, Zomig ZMT 3 (AstraZeneca) 2.5 mg ...
Eletriptan hydrobromide (Relpax Pfizer) is now available in the US for oral treatment of migraine headache in adults. It is the seventh serotonin 5-HT1B/1D-receptor agonist (triptan) to be approved by the FDA for this indication. This review describes the pharmacokinetics, adverse effects, drug interactions and recommended dosage of eletriptan. Clinical trials comparing the new drug to placebo and to sumatriptan are presented. A dosage and cost table for all the triptans available in the US is also included. The review concludes with an overall assessment of eletriptan's efficacy and...
Med Lett Drugs Ther. 2003 Apr 28;45(1155):33-4 |  Show IntroductionHide Introduction

Drugs for Migraine

   
The Medical Letter on Drugs and Therapeutics • Jun 12, 2023  (Issue 1678)
receptor agonists (triptans) sumatriptan, almotriptan, eletriptan, rizatriptan, and zolmitriptan ...
An oral nonopioid analgesic is often sufficient for acute treatment of mild to moderate migraine pain without severe nausea or vomiting. A triptan is the drug of choice for treatment of moderate to severe migraine in most patients without vascular disease. Treatment of pain when it is still mild to moderate in intensity improves headache response and reduces the risk of recurrence.
Med Lett Drugs Ther. 2023 Jun 12;65(1678):89-96   doi:10.58347/tml.2023.1678a |  Show IntroductionHide Introduction

Sulfonamide Cross-Reactivity

   
The Medical Letter on Drugs and Therapeutics • Mar 25, 2019  (Issue 1568)
, zolmitriptan Others Sulfasalazine2, tamsulosin, zonisamide 1. Triptans contain a sulfonyl group, which ...
A reader has questioned why the label for the COX-2 selective NSAID celecoxib (Celebrex, and generics), which contains a sulfonamide moiety, states that it is contraindicated for use in patients with an allergy to sulfonamides, while the labels of some other sulfonamide drugs recommend either caution or no precautions at all. The concept of cross-reactivity among sulfonamide drugs, particularly between antibacterial and nonantibacterial sulfonamides, has been controversial for many years.
Med Lett Drugs Ther. 2019 Mar 25;61(1568):44-6 |  Show IntroductionHide Introduction

Lasmiditan (Reyvow) and Ubrogepant (Ubrelvy) for Acute Treatment of Migraine

   
The Medical Letter on Drugs and Therapeutics • Mar 09, 2020  (Issue 1593)
(Upsher-Smith) (max 12 mg/day) Zolmitriptan – generic 2.5, 5 mg tabs 2.5 or 5 mg PO; can be repeated 7.00 ...
Lasmiditan (Reyvow – Lilly), an oral serotonin (5-HT1F) receptor agonist, and ubrogepant (Ubrelvy – Allergan), an oral calcitonin gene-related peptide (CGRP) receptor antagonist, have been approved by the FDA for acute treatment of migraine with or without aura in adults.
Med Lett Drugs Ther. 2020 Mar 9;62(1593):35-9 |  Show IntroductionHide Introduction